SecBot SecBot
8-K ·Filed Jul 29, 2026

FTRE

Fortrea Holdings Inc.
MIXED
Impact 6/10
Horizonweeks Processed3mo ago SEC0001628280-26-050368
8-K Item 2.02: Earnings release
Actionable Insight ◆ Mixed

The strong earnings beat and guidance raise are positive, but the CFO legal issue introduces material uncertainty. Monitor the litigation outcome and any further management departures. The raised guidance suggests underlying business momentum, but the leadership disruption could weigh on the stock near term.

DirectionMixed
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
FTRE ▲ +17.25% at T+60d
NEUTRAL call +17.25% · α vs SPY +12.53% · entry $20.40 → $23.92
Entry = T+0 close
Jul 29, 2026
via day close
T+1d
-6.47%
call -6.47% · α -8.15%
$19.08
settled 3mo ago
T+5d
-6.62%
call -6.62% · α -12.15%
$19.05
settled 3mo ago
T+20d
-9.17%
call -9.17% · α -14.19%
$18.53
settled 2mo ago
T+60d
+17.25%
call +17.25% · α +12.53%
$23.92
settled 5d ago

Price Chart

Loading chart...

Executive Summary

Fortrea reported Q2 2026 adjusted EPS of $0.23, beating consensus by 27.8%, and raised full-year 2026 guidance, signaling improving operational momentum. However, the company simultaneously disclosed that its newly appointed CFO, Jason Knoblauch, has been placed on paid leave due to a temporary restraining order from the Delaware Court of Chancery in a lawsuit by his prior employer, creating significant leadership uncertainty.

Key Financial Metrics

EPS
$0.23
est $0.18 · +27.8%
Revenue
$678.2M
est $647.6M · +4.7% · -4.5% YoY
Rating
strong beat
Guidance
$2,620M-$2,690M
raised
Free Cash Flow
$19.9M

Key Facts

  • Q2 2026 revenue $678.2M vs consensus $647.6M (beat by 4.7%), but down 4.5% YoY from $710.3M
  • Adjusted diluted EPS $0.23 vs consensus $0.18 (beat by 27.8%)
  • Full-year 2026 guidance raised: revenue $2,620M-$2,690M (prev. $2,550M-$2,650M), adjusted EBITDA $205M-$220M (prev. $190M-$220M)
  • Q2 book-to-bill 1.06x, fourth consecutive quarter above 1.0x; backlog $7.8B
  • CFO Jason Knoblauch placed on paid leave after court order; interim CFO David Smith appointed
  • Q2 operating cash flow $28.9M, free cash flow $19.9M

Financial Impact

Adjusted EPS beat by $0.05 (27.8%) and revenue beat by $30.6M (4.7%); guidance raise implies ~$55M incremental revenue at midpoint

revenueadjusted EPSadjusted EBITDAguidancebook-to-bill

Risk Factors

  • CFO litigation could result in damages or reputational harm
  • Revenue still declining YoY (-4.5%) despite beat
  • GAAP net loss continues ($13.2M in Q2)
  • Interim CFO may lack continuity; potential for further executive turnover

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
59% bullish (17 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-050368
Document: ftre-20260727.htm0001628280-26-050368
Document: 0001628280-26-050368-index-headers.html0001628280-26-050368
Document: 0001628280-26-050368-index.html0001628280-26-050368
Document: 0001628280-26-050368.txt0001628280-26-050368
8-K Data (Synthetic)0001628280-26-050368
22 reports for FTRE
Performance horizon
100% Hit rate @ T+1 3 of 3 directional calls Went positive at some point 3 of 3 best @ T+20▲ +11.57%Feb 26, 2026
Filters
Rows
Reports for FTRE — sortable, filterable
TypeNow
Oct 27, 2026
today
Press Release
NEUTRAL ★ 2/10
$23.63awaiting T+1—$24.43 (+3.39%)
Oct 22, 2026
5d ago
Press Release
NEUTRAL ★ 3/10
$23.63 $23.83▲ +0.85%▲ +0.14%$24.43 (+3.39%)
Oct 19, 2026
8d ago
Press Release
BULLISH ★ 5/10
$22.78 $24.06▲ +5.62%▲ +5.09%$24.43 (+7.24%)
Oct 5, 2026
22d ago
Press Release
NEUTRAL ★ 1/10
$21.11 $20.78▼ −1.56%▼ −2.11%$24.43 (+15.73%)
Sep 30, 2026
26d ago
8-K
NEUTRAL ★ 2/10
$19.40 $20.00▲ +3.09%▲ +2.35%$24.43 (+25.93%)
Sep 10, 2026
6w ago
Press Release
NEUTRAL ★ 2/10
$17.20 $17.41▲ +1.22%▲ +1.67%$24.43 (+42.03%)
Sep 10, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$17.02 $17.20▲ +1.06%▲ +0.21%$24.43 (+43.54%)
Sep 2, 2026
7w ago
Press Release
BULLISH ★ 6/10
$18.36 $18.62▲ +1.42%▲ +0.37%$24.43 (+33.06%)
Aug 22, 2026
9w ago
Institutional Cluster
MIXED ★ 5/10
$18.31 $18.27▼ −0.22%▼ −0.54%$24.43 (+33.42%)
Aug 7, 2026
11w ago
Insider Cluster
MIXED ★ 5/10
$18.99 $19.52▲ +2.79%▲ +3.11%$24.43 (+28.65%)
Showing 10 of 22

US Market Status

Market Closed — Opens Wed (17h 25m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 29, 2026